Interesting ImagesIncidentally Detected 18F-PSMA Uptake in Glomus JugulareZade, Anand DNB; Trivedi, Chintan MD; Ingule, Amol MD; Jha, Smriti DNB; Agrwal, Anup MDAuthor Information From the Department of Radiology, Apollo Hospitals, Navi Mumbai, India. Received for publication July 30, 2019; revision accepted April 10, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Anand Zade, DNB, Department of Nuclear Medicine, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai 4000614, India. E-mail: firstname.lastname@example.org. Clinical Nuclear Medicine: August 2020 - Volume 45 - Issue 8 - p e360-e362 doi: 10.1097/RLU.0000000000003117 Buy Metrics Abstract PSMA (prostate-specific membrane antigen) PET/CT scan is the imaging modality of choice for staging and restaging of carcinoma prostate. Although initially thought to be a tracer with high specificity for prostatic tissue, with its extensive clinical use, there has been a rise in published literature citing its uptake in nonprostatic conditions. We present a case where false-positive PSMA uptake was noted in glomus jugulare during staging workup for carcinoma prostate. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.